FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Alert on Synovo Hip Implants

FDA alerts healthcare providers to not purchase or implant Synovos Total Hip System because modifications to the original device design were not clear...

latest-news-card-1
Biologics

EUA Filed for Covid Prevention in Immunocompromised

Invivyd seeks FDA emergency use authorization for VYD222, which is described as a broadly neutralizing, half-life extended monoclonal antibody candida...

latest-news-card-1
Medical Devices

QS Violations at Swedens Sonesta Medical

FDA warns Solna, Sweden-based Sonesta Medical about Quality System violations in its manufacturing of three medical devices.

latest-news-card-1
Medical Devices

DHT Remote Data Acquisition Guidance

FDA publishes a guidance with recommendations on using digital health technologies for remote data acquisition.

Animal Drugs

Animal MUMS Drug Guidance

FDA publishes a guidance to assist sponsors in seeking approval of new animal drugs for minor uses or minor species.

latest-news-card-1
Human Drugs

CRL for Amgen Lumakras sNDA

FDA requires an additional postmarketing confirmatory study for full approval of Amgens Lumakras non-small cell lung cancer treatment that obtained ac...

latest-news-card-1
Human Drugs

FDA OKs Arcutis Zoryve Topical Foam for Dermatitis

FDA approves Arcutis Biotherapeutics Zoryve topical foam to treat seborrheic dermatitis in individuals aged nine and older.

latest-news-card-1
Human Drugs

Complete Response Letter for Zealand Infant Drug

FDA issues a complete response letter for Zealand Pharmas dasiglucagon based on deficiencies at a third-party manufacturing facility.

latest-news-card-1
Human Drugs

FDA Updates Kite Yescarta Label

FDA approves a label update for Kites Yescarta to include the overall survival primary analysis from the landmark Phase 3 Zuma-7 study.

latest-news-card-1
Human Drugs

No Info from Singapore Drug Company

FDA warns Singapores Wipro Unza Singapore Private, Limited, about refusing to respond to two agency records requests for information on the firms manu...